Boris Peaker, Ph.D., CFA

Managing Director, Health Care - Biotechnology

Headshot photo of Boris Peaker

Boris Peaker is a managing director and senior research analyst covering emerging growth biotechnology companies. Prior to rejoining Cowen in 2014, Dr. Peaker was a senior analyst at Oppenheimer & Co. and Rodman & Renshaw, covering large-, mid-, and small-cap biotechnology stocks. Dr. Peaker holds a BS in physics and chemistry from Stony Brook University and a Ph.D. in biophysics from Stanford University. He is a CFA charterholder. HCBiopharma

Get In Touch

Start a conversation with Boris Peaker

    Insights

    Explore related thought leadership, reports, coverage and insights for Boris Peaker.

    Medical researcher conducting pharmaceutical research in a lab. Representing innovative therapies for fighting cancer i.e., immuno-oncology
    Ahead of the Curve®

    Investors Guide to Immuno-Oncology

    Ahead of the Curve®

    5th Annual Investor Primer on Antibody Drug Conjugates

    Best ESG Investment Ideas for 2023